Alzheimer’s Disease/Dementia News

SAN DIEGO – AmyriAD Therapeutics is focusing on the upregulation of neurotransmission to improve cognition and global function in patients with Alzheimer’s disease, according to CEO Sharon L. Rogers, PhD.

SAN DIEGO – Regardless of dementia type, patients with nonamnestic symptoms showed a faster rate of functional decline than those amnestic symptoms, according to a study presented at the Alzheimer’s Association International Conference.

Treatment with sildenafil or tadalafil was not associated with a reduced risk for incident Alzheimer’s disease and related dementia in patients with pulmonary hypertension, according to a study published in Brain Communications.

SAN DIEGO – People should increase their exercise to reduce the risk of dementia or slow its progression, said a lecturer at the Alzheimer’s Association International Conference.

Alzamend Neuro has submitted an investigational new drug application to the FDA for its Alzheimer’s immunotherapeutic product, ALZN002, according to a company press release.

Corium Inc. announced that Adlarity transdermal treatment is available to prescribe in the U.S. for patients with Alzheimer’s.

SAN DIEGO – One compound from Annovis Bio is showing success in phase 2 clinical trials for both Alzheimer’s disease and Parkinsons’ disease, a company executive said at the Alzheimer’s Association International Conference.

Higher levels of the inflammatory marker C-reactive protein predicted lower reported cognitive function among older breast cancer survivors, according to study results published in Journal of Clinical Oncology.

The NIH has awarded a $10.7 million 5-year renewal grant to Cleveland Clinic to expand a national research consortium focused on improving the diagnosis and treatments for dementia with Lewy bodies.

Researchers identified a correlation between eGFR and urine albumin-creatinine ratio with structural brain damage across various regions of etiology, according to data published in the American Journal of Kidney Diseases.